YS Biopharma’s PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval in Pakistan
GAITHERSBURG, Md., May 16, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced its PIKA Rabies Vaccine has received Phase 3...
MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer
MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this...
Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts
EAST RUTHERFORD, N.J., May 16, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that Snapdragon Chemistry has completed the second phase of its 51,000 square foot expansion in Waltham, Massachusetts. This...
WuXi Biologics Announces Manufacturing Partnership with InflaRx to Advance Gohibic for the Treatment of Certain Critically Ill COVID-19 patients
WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class monoclonal anti-C5a antibody. InflaRx received emergency use authorization (EUA) from the FDA for Gohibic (vilobelimab) for the treatment of certain critically ill COVID-19 patients in April 2023. WuXi Biologics will leverage its global manufacturing network and dual-sourcing strategy to support InflaRx in making Gohibic available...
LG Chem Targets Sixfold Sales Growth in Battery Materials to KRW 30 Trillion by 2030
- Will expand sales portion in battery materials, sustainability business and innovative new drugs - Aims to accelerate in reaching net zero by 2050 by proactively building an integrated low-carbon management system SEOUL, South Korea, May 16, 2023 /PRNewswire/ -- LG Chem today announced its business strategy to leap up to become a top global battery materials company and its...
Medit continues to see strong scanner adoption in Q1 2023
Medit intraoral scanner installation is growing at almost 50% vs PY Medit Link serves as a key differentiator that has the potential to become the cornerstone of digital dentistry SEOUL, South Korea and LONG BEACH, Calif., May 16, 2023 /PRNewswire/ -- Medit (www.medit.com), a leading provider of 3D intraoral scanners...
LYNK’s LNK01001 Achieved Exciting Phase II Results in Rheumatoid Arthritis
HANGZHOU, China, May 16, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that the Phase II clinical trial of LNK01001 in the treatment of rheumatoid arthritis (RA) showed statistically significant differences in efficacy compared with placebo in both primary and key secondary efficacy endpoints, and demonstrated good safety...
China International Medical Equipment Fair 2023 Held in Shanghai in May, Showcasing Cutting-Edge Healthcare Technologies
SHANGHAI, May 15, 2023 /PRNewswire/ -- The 87th edition of the China International Medical Equipment Fair (CMEF) has opened its door to the world in Shanghai. Hosted from May 14 – 17th, the show once again brought together the latest and the great solutions created to drive innovations and push the boundaries of the healthcare field to address the...
Patient Enrollment Completed for Phase III Clinical Trial of Boan Biotech’s Dulaglutide Injection BA5101 in China
YANTAI, China, May 15, 2023 /PRNewswire/ -- Boan Biotech today announced the completion of patient enrollment for the Phase III clinical trial (a comparative clinical study of efficacy and safety) of the company's Dulaglutide Injection (BA5101) in China. BA5101 is a biosimilar of Trulicity®, used for glycemic control in adults with insufficiently controlled type 2 diabetes mellitus. The Phase...
CMUH Smart Medicine System Assisted the ARDS Specialist Team Successfully Reversed the Patient’s Critical Condition
TAICHUNG,Taiwan, May 15, 2023 /PRNewswire/ -- After the worldwide COVID-19 pandemic, most people suffered from mild disease, and "Acute Respiratory Distress Syndrome (ARDS)" is common for those critical COVID-19 patients. The 46-year-old of Ms. Chang, who had hypertension and nephropathy, accepted kidney transplantation surgery 10 years ago. She was tested positive for COVID-19 and had severe respiratory failure. Ms. Chang was...
